Understanding how individuals vary on disease susceptibility is becoming increasingly important for clinicians to deliver effective treatment to their patients. For example, some patients are fortunate to survive cancer multiple times, while others die within a few months of their diagnosis. This variation can be addressed by studying genomic data, which offers precise insights into risk of disease and subsequent prognosis.
